Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis
Mohammad Shadab Siddiqui, Dhruvanshu Parmar, Farheen Sheikh, Shiv Kumar Sarin, Laura M. Cisneros, Samer Gawrieh, Taufik Momin, Ajay Duseja, Arun J. Sanyal
Topics & Concepts
MedicineInternal medicineEndocrinologyDiabetes mellitusPlaceboTriglycerideCholesterolNonalcoholic fatty liver diseaseLipoproteinGastroenterologyFatty liverDiseasePathologyAlternative medicineLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationPeroxisome Proliferator-Activated Receptors